126 results on '"Prashar S"'
Search Results
2. Is objective cure of mild undifferentiated incontinence more readily achieved than that of moderate incontinence? Costs and 2-year outcome
3. Attitudes to Vaginal/Urethral Touching and Device Placement in Women with Urinary Incontinence
4. Audit of laparoscopic surgery for tubal pregnancy in a district general hospital
5. Randomised controlled trial of nurse continence advisor therapy compared with standard urogynaecology regimen for conservative incontinence treatment: efficacy, costs and two year follow up
6. 199 Effects of dietary supplementation with ground red-osier dogwood (Cornus stolonifera) on oxidative status in weaned pigs challenged with Escherichia coli K88+.
7. EFFICACY AND USER ACCEPTABILITY OF THE URETHRAL OCCLUSIVE DEVICE IN WOMEN WITH URINARY INCONTINENCE
8. Active component composition and efficacy variability in North American ginseng
9. Postmortem Distribution of Tapentadol and N-Desmethyltapentadol
10. Discovery and genotyping of high-throughput SNP markers for crown rust resistance gene Pc94 in cultivated oat
11. Use of the Dowell Bryant Incontinence Cost Index as a post-treatment outcome measure after non-surgical therapy
12. Laparosopic sacrocolpopexy in the management of vaginal vault prolapse
13. Incarcerated retroverted uterus in the third trimester complicated by postpartum pulmonary embolism.
14. Use of the Dowell Bryant Incontinence Cost Index as a post-treatment outcome measure after non-surgical therapy.
15. A Novel Constrained-Geometry Niobocene Complex with a Phosphanidoalkylcyclopentadienyl Ligand: [Nb(N<SUP>t</SUP>Bu){(η<SUP>5</SUP>-C<INF>5</INF>H<INF>4</INF>)CMe<INF>2</INF>PPh-κP}{(η<SUP>5</SUP>-C<INF>5</INF>H<INF>4</INF>)CMe<INF>2</INF>PHPh}]
16. New Synthon in the Design of ansa-Cyclopentadienyl Ligands with Variable Substitution at the Bridging Atom
17. Hydrosilylation in the Design and Functionalization of ansa-Metallocene Complexes
18. Reactivity of Zirconium Complexes Incorporating Asymmetrically Substituted ansa Ligands and Their Use as Catalysts in Olefin Polymerization. X-ray Crystal Structures of [Me<INF>2</INF>Si(η<SUP>5</SUP>-C<INF>5</INF>Me<INF>4</INF>)(η<SUP>5</SUP>-C<INF>5</INF>H<INF>3</INF>R)]ZrCl<INF>2</INF> (R = Et, <SUP>i</SUP><SUP></SUP>Pr)
19. Synthesis, Structure, and Reactivity of Niobocene Imido Complexes Containing Alkynyl Ligands. X-ray Crystal Structure of [Nb(&dbd;NPh)(η<SUP>5</SUP>-C<INF>5</INF>H<INF>4</INF>SiMe<INF>3</INF>)<INF>2</INF>(C&tbd1;CPh)]
20. The synthesis of alkyl niobocene imido complexes and the X-ray crystal structure of [Nb(O)Cp2Me] (Cp=5-C5H5)
21. Niobium and Zirconium Complexes Incorporating Asymmetrically Substituted ansa Ligands. X-ray Crystal Structures of [Me<INF>2</INF>Si(η<SUP>5</SUP>-C<INF>5</INF>Me<INF>4</INF>)(η<SUP>5</SUP>-C<INF>5</INF>H<INF>3</INF>R)]Nb(&dbd;N<SUP>t</SUP><SUP></SUP>Bu)Cl (R = Me, <SUP>i</SUP><SUP></SUP>Pr) and [Me<INF>2</INF>Si(η<SUP>5</SUP>-C<INF>5</INF>Me<INF>4</INF>)(η<SUP>5</SUP>-C<INF>5</INF>H<INF>3</INF>R)]ZrCl<INF>2</INF> (R = H, Me)
22. Syntheses and crystal structures of two ytterbocene complexes [Yb(-Cpprimeprime)2I(THF)] and [Yb(-Cpprimeprime)2(m-Cl)2Li(THF)2] (Cpprimeprime=C5H3(SiMe3)2-1,3)
23. A Cost Effective Solution to Security Constrained Unit Commitment and Dispatch Problem using Hybrid Search Algorithm
24. Sandwich and half-sandwich niobium imido complexes: X-ray crystal structure of [Nb(NAr)Cp'2Cl] (Cp'=@h^5-C5H4SiMe3, Ar=C6H4OMe-4)
25. Insertion reactions of heterocumulenes into the niobium hydride bond of isocyanide and carbonyl niobocene complexes
26. Studies on the Insertion Reactions of Activated Alkynes into Nb−H Bonds in Hydride−Niobocene Complexes. X-ray Crystal Structures of Nb(η<SUP>5</SUP>-C<INF>5</INF>H<INF>4</INF>SiMe<INF>3</INF>)<INF>2</INF>(H)[η<SUP>2</SUP>-RO<INF>2</INF>C(H)&dbd;C(H)CO<INF>2</INF>R] (R = Me or <SUP>t</SUP>Bu)
27. Synthesis and Reactivity of Novel Niobocene Complexes Containing Allyl or 1-Azaallyl Ligands. X-ray Crystal Structure of [Li{η<SUP>3</SUP>-N(SiMe<INF>3</INF>)C(<SUP>t</SUP><SUP></SUP>Bu)CH<INF>2</INF>}]<INF>3</INF>
28. New ansa-Niobocene Complexes. X-ray Crystal Structure of [Me<INF>2</INF>Si(η<SUP>5</SUP>-C<INF>5</INF>H<INF>4</INF>)<INF>2</INF>]Nb(&dbd;N<SUP>t</SUP><SUP></SUP>Bu)Cl. Stereoselective Synthesis of meso-[Me<INF>2</INF>Si(η<SUP>5</SUP>-C<INF>5</INF>H<INF>3</INF>SiMe<INF>3</INF>)<INF>2</INF>]Nb(&dbd;N<SUP>t</SUP><SUP></SUP>Bu)Cl
29. Diabetes and periodontitis
30. New group 4 metallocene and niobocene complexes containing phosphane-functionalized ansa-ligands
31. Studies on the insertion reactions of activated alkynes into Nb-H bonds in hydride-niobocene complexes. X-ray crystal structures of Nb(η5-C5H4SiMe3) 2(H)[η2-RO2C(H)=C(H)CO2R] (R = Me or tBu)
32. 2-layer and 3-layer fiber geometry model based analysis of refractive index sensitivity of long period fiber grating with reduced cladding
33. Oculo-auricular cranial dysplasia.
34. ansa-Niobocene Complexes: Synthesis and Characterization of Novel Complexes [Me<INF>2</INF>Si(η<SUP>5</SUP>-C<INF>5</INF>H<INF>4</INF>)<INF>2</INF>]NbCl<INF>2</INF> and [Me<INF>2</INF>Si(η<SUP>5</SUP>-C<INF>5</INF>H<INF>4</INF>)<INF>2</INF>]NbCl(RC&tbd1;CR) (R = Me, Ph). X-ray Crystal Structure of [Me<INF>2</INF>Si(η<SUP>5</SUP>-C<INF>5</INF>H<INF>4</INF>)<INF>2</INF>]NbCl(MeC&tbd1;CMe)
35. Role of vesicular monoamine transporter-2 for treating attention deficit hyperactivity disorder: a review.
36. Unleashing the antibacterial and antibiofilm potential of silica-based nanomaterials functionalized with an organotin(IV) compound.
37. Vanadocene-functionalized mesoporous silica nanoparticles: platforms for the development of theranostic materials against breast cancer.
38. Melatonin Derivative-Conjugated Formulations of Pd(II) and Pt(II) Thiazoline Complexes on Mesoporous Silica to Enhance Cytotoxicity and Apoptosis against HeLa Cells.
39. Mean performances, character associations and multi-environmental evaluation of chilli landraces in north western Himalayas.
40. Organotin(IV)-Decorated Graphene Quantum Dots as Dual Platform for Molecular Imaging and Treatment of Triple Negative Breast Cancer.
41. Substance use and misuse among college students: Results of an online survey from three neighboring cities of North India.
42. Radioactive Iodine Uptake in Postoperative Seroma: A Cause for False Positivity.
43. Dual Anticancer and Antibacterial Properties of Silica-Based Theranostic Nanomaterials Functionalized with Coumarin343, Folic Acid and a Cytotoxic Organotin(IV) Metallodrug.
44. Biological Use of Nanostructured Silica-Based Materials Functionalized with Metallodrugs: The Spanish Perspective.
45. Cytotoxic and DNA-binding Capacity of Titanocene Functionalized Mesoporous Nanoparticles in Breast Cancer Cell Lines MCF-7 and MDA-MB-231.
46. False positive finding on whole-body iodine-131 scan secondary to contaminated face mask: an uncommon peril in current COVID pandemic.
47. Design of Mesoporous Silica Nanoparticles for the Treatment of Amyotrophic Lateral Sclerosis (ALS) with a Therapeutic Cocktail Based on Leptin and Pioglitazone.
48. A cross-sectional study to assess the pre-marital sexual practices among Panjab University students, Chandigarh, India.
49. Synthesis of a theranostic platform based on fibrous silica nanoparticles for the enhanced treatment of triple-negative breast cancer promoted by a combination of chemotherapeutic agents.
50. Tin-loaded mesoporous silica nanoparticles: Antineoplastic properties and genotoxicity assessment.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.